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Abstract 
The presence of chemicals in the environment raises concerns in relation to their potential 
adverse effects on human and environmental health. Personal care products (PCPs) are 
used daily by a large part of the human population and have been increasingly found in 
the environment. They end up in surface waters mainly through domestic and industrial 
wastewater discharges. Despite their relatively low toxicity, these chemicals constitute a 
threat to the aquatic ecosystems, since they may accumulate in aquatic organisms and 
adsorb to suspended solids and sediments. Polycyclic musks are known to interfere with 
the multixenobiotic resistance (MXR) defense mechanism of cells and, together with 
diethyl phthalate (DEP), they impair the cellular structure and cell functions. In this 
context, the potential of the polycyclic musks tonalide (AHTN) and galaxolide (HHCB) and 
the phthalate ester DEP to cause toxicity in rainbow trout (Oncorhynchus mykiss) was 
assessed. Acute in vitro exposure of O. mykiss hepatocytes to single and binary mixtures 
of PCPs was performed. Cytotoxicity caused by single PCPs was evaluated through the 
application of the fluorescent probes alamar blue (AB), 5-carboxyfluorescein diacetate 
actetoxymethyl ester (CFDA-AM) and monochlorobimane (mBCl), which allows the 
measurement of the levels of cell mitochondrial activity, membrane integrity and oxidative 
stress, respectively. Furthermore, the potential of single and combined PCPs to inhibit the 
activity of ABC transporters in cells was evaluated. To better understand the toxicity of 
mixtures, comparisons between experimental results and concentration addition (CA) and 
independent action (IA) model predictions were done. PCPs caused cytotoxic effects on 
O. mykiss hepatocytes, namely a dose-dependent decrease of cellular mitochondrial 
activity and membrane integrity, and induction of oxidative stress. The lowest EC50 values 
for PCPs corresponded to membrane integrity impairment: 111.40 × 10-6 M for AHTN, 
3.67 × 10-6 M for HHCB and 25.31 × 10-3 M for DEP. In relation to oxidative stress, 
hepatocytes seem to cope with low concentrations of AHTN (0.02–23.3 × 10-6 M), HHCB 
(0.02–2.3 × 10-6 M) and DEP (2.3–20000 × 10-6 M). However, impairment of the 
antioxidant defense system seems to occur at higher concentrations. Furthermore, 
hepatocytes exposed to single and binary mixtures of PCPs presented a dose-dependent 
decrease in cellular ABC transporter activity. Therefore, the tested compounds induced 
cytotoxic effects on rainbow trout hepatocytes and inhibited the MXR defense system of 
cells, consequently acting as chemosensitizers. HHCB was the most toxic compound for 
rainbow trout hepatocytes, followed by AHTN and DEP. Model predictions indicated 
toxicological interactions when the compounds were tested in binary mixtures, namely 
antagonism caused by the HHCB/DEP mixture. The effects of the AHTN/HHCB mixture 
revealed to be additive. In general, these findings highlight the importance of diagnosing 
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the presence of potential MXR inhibitors in the environment and the need of more 
research on the toxic effects caused by chemical mixtures. Aquatic organisms, including 
fish, become more susceptible to the potential adverse effects caused by exposure to 
xenobiotics if the MXR defense system is compromised, especially under exposure to 
chemicals able to cause synergistic effects.  
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Resumo 
A presença de substâncias químicas no ambiente gera preocupações devido aos seus 
potenciais efeitos negativos na saúde humana e ambiental. Os produtos de higiene e 
cuidado pessoal (PCPs) são usados diariamente por uma grande parte da população e, 
portanto, estão cada vez mais presentes no ambiente. Através de descargas de águas 
residuais domésticas e industriais, estes compostos acabam por surgir em águas de 
superfície. Apesar da sua relativamente reduzida toxicidade, estas substâncias químicas 
constituem uma ameaça para os ecossistemas aquáticos, uma vez que podem acumular 
em organismos aquáticos e adsorver a sedimentos e sólidos em suspensão. Os 
almíscares policíclicos são conhecidos por interferir com o sistema de resistência a 
multixenobióticos (MXR) das células e, em conjunto com o dietil ftalato (DEP), prejudicam 
a estrutura e funções celulares. Neste contexto, no presente estudo, foi avaliada a 
toxicidade dos almíscares policíclicos tonalide (AHTN) e galaxolide (HHCB) e o éster de 
ftalato DEP para a truta arco-íris (Oncorhynchus mykiss). Procedeu-se à exposição 
aguda in vitro de hepatócitos de O. mykiss a PCPs individuais e em misturas binárias. A 
citotoxicidade causada pelos PCPs foi avaliada através da aplicação das sondas 
fluorescentes alamar blue (AB), 5-carboxifluoresceína diacetato acetoximetil éster (CFDA-
AM) e monoclorobimane (mBCl), que permitem medir o nível de atividade mitocondrial, 
integridade da membrana e estresse oxidativo da célula, respetivamente. Para além 
disso, foi avaliado o potencial dos PCPs individuais e em mistura de inibirem a atividade 
dos transportadores ABC nas células. De forma a compreender melhor a toxicidade de 
misturas, foram feitas comparações entre os resultados experimentais e as previsões dos 
modelos concentração adição (CA) e ação independente (IA). Os PCPs causaram efeitos 
citotóxicos em hepatócitos de O. mykiss, nomeadamente um decréscimo dose 
dependente na atividade mitocondrial e integridade da membrana celular e, indução de 
estresse oxidativo. Para os PCPs testados, os valores de EC50 mais baixos 
corresponderam aos efeitos causados sob a integridade da membrana: 111.40 × 10-6 M 
para AHTN, 3.67 × 10-6 M para HHCB e 25.31 × 10-3 M para DEP. Relativamente ao 
estresse oxidativo, os hepatócitos parecem conseguir lidar com concentrações baixas de 
AHTN (0.02–23.3 × 10-6 M), HHCB (0.02–2.3 × 10-6 M) e DEP (2.3–20000 × 10-6 M). No 
entanto, a concentrações mais elevadas, o sistema de defesa antioxidante parece ser 
prejudicado. Para além disso, os hepatócitos expostos a PCPs individuais e em mistura, 
apresentaram um decréscimo dose dependente na atividade dos transportadores ABC 
nas células. Assim, os compostos testados induziram efeitos citotóxicos em hepatócitos 
de truta arco-íris e inibiram o sistema de defesa MXR e, consequentemente, podem atuar 
como quimio-sensibilizantes. HHCB provou ser o composto mais tóxico para hepatócitos 
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de truta arco-íris, seguido do AHTN e DEP. As previsões dos modelos matemáticos 
indicaram interações toxicológicas entre as substâncias testadas, nomeadamente 
antagonismo no caso da mistura HHCB/DEP. Os efeitos da mistura AHTN/HHCB 
revelaram ser aditivos. De uma forma geral, estes resultados alertam para a importância 
de diagnosticar a presença de potenciais inibidores do sistema MXR no ambiente e, para 
a necessidade de investigar os efeitos tóxicos causados por misturas de substâncias 
químicas. Os organismos aquáticos, incluindo os peixes, tornam-se mais suscetíveis a 
potenciais efeitos adversos causados pela exposição a xenobióticos, se o sistema de 
defesa MXR estiver comprometido, especialmente na exposição a substâncias químicas 
que causam efeitos sinérgicos.  
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1. Introduction 
1.1. Personal care products 
Personal care products (PCPs) are a group of compounds used in a wide range of 
products including fragrances, disinfectants, insect repellants, preservatives and UV filters 
(Brausch & Rand, 2011). Large amounts of these chemicals are produced and consumed 
worldwide and consequently released into the environment. As foreign substances to the 
organism - xenobiotics - these chemicals constitute a class of priority pollutants known as 
pharmaceuticals and personal care products (PPCPs). So far, the main focus in this field 
has been the study of the adverse effects of pharmaceuticals on non-target organisms 
and on ecosystems; PCPs have not received sufficient attention due to their assumed 
relatively low toxicity and environmental risk. However, it has to be taken into 
consideration the presence of PCPs in the aquatic ecosystem and their potential to affect 
non-target organisms through interference with multixenobiotic resistance (MXR) efflux 
transporters (Luckenbach & Epel, 2005). Even if certain chemicals themselves have a 
non-toxic to slightly toxic effect on aquatic organisms, they might be responsible for 
inhibiting the MXR defense system of cells, leading to an intracellular accumulation of 
xenobiotics and a more susceptible individual (Smital et al., 2004). Brausch & Rand 
(2011) discovered that in aquatic environments, PCPs have been found more frequently 
and at higher concentrations than pharmaceuticals. As a result of their continuous release 
into sewers, these chemicals are commonly detected in surface waters and become 
persistent in the environment. Furthermore, some PCPs are bioactive and have the 
potential to bioaccumulate in aquatic organisms (Brausch & Rand, 2011).  
1.1.1. Synthetic musks 
The use of natural musk fragrances was overtaken for decades. Since the 1950s, 
synthetic musks became an easy and cheap solution to fill the world with scent but around 
the 1980s they started to be detected in the environment and be seen as a potential 
health threat (Bester, 2009). A huge variety of products contain these artificial fragrances, 
including perfumes, creams, soaps, detergents and deodorants (Nakata et al., 2007). 
Synthetic musks can be divided into three major classes: nitro-aromatic, polycyclic and 
macrocyclic musks (Bester, 2009). Nowadays, polycyclic musks are prevalent in the 
market since they are widely used in replacement of certain nitro musks whose usage was 
banned or reduced (Hutter et al., 2009; International Fragrance Association, 2011). In 
1987, polycyclic musks comprised 61% of the total amount of synthetic musks produced 
in the world. The trend seems to be an increasing production and usage of polycyclic 
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musks over the years, particularly Tonalide® (AHTN) and Galaxolide® (HHCB), which are 
produced in very high volumes in both Europe and the United States (Nakata et al., 2007). 
The main fragranced products containing polycyclic musks are cosmetics and household 
cleaning products, which in the future will possibly be replaced by macrocyclic musks for 
having a more intensive smell and requiring lower concentrations (Bester, 2009). 
1.1.2. Phthalates 
Phthalate esters are a family of chemicals mainly used as plasticizers and softeners to 
produce more flexible and resilient polymers. In addition to its application in numerous 
consumer products made of plastic and vinyl (toys, food packaging, electronics, medical 
devices, building materials), phthalates are frequently used in cosmetics and personal 
care products to make fragrance or color last longer, since they have a fixation capacity 
(Zheng et al., 2013; Hubinger, 2010). They are included in perfumes, bath products, 
lotions, hair sprays, nail polish and detergents (Kang et al., 2010). In cosmetics, they can 
perform the function of skin moisturizers, skin softeners and skin penetration enhancers 
(Hubinger, 2010). Phthalates are not covalently bound to raw materials and therefore can 
be easily released into the environment through leaching, migration and evaporation 
processes (Zheng et al., 2013). This results in the presence of these chemicals in water 
ecosystems at measurable concentrations due to its increasing production and constant 
release in effluents (Zheng et al., 2013). The most common phthalate used as solvent and 
vehicle for fragrance and cosmetic ingredients is diethyl phthalate (DEP; American 
Chemistry Council, 2014). Its main environmental contamination sources are the 
synthesis processes and the utilization and disposal of its final products with consequent 
leaching from landfill sites (Kang et al., 2010). Although DEP is present in all 
environmental compartments, water contamination generates the greatest concern 
(Hubinger, 2010).  
1.1.3. Fate and exposure  
The aquatic ecosystems may be the final reservoir for xenobiotics intentionally or 
accidentally released into the environment. As mentioned earlier, the environment is 
constantly being subjected to the presence of anthropogenic contaminants that endanger 
the natural functions of an ecosystem. Personal care products are not an exception. 
Continuously discharged in effluents, they end up in freshwater and marine environments 
and eventually accumulate in sediments, sludges and biota due to their lipophilic nature 
(Bester, 2009). This lends to PCPs some characteristics of persistent pollutants, despite 
their degradability and relative short environmental half-lives. This means, organisms that 
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are in constant contact with contaminated water, especially those living close to 
wastewater treatment facilities, concentrate the substances from the water but, at the 
same time, are able to transform them to more polar metabolites that are more easily 
excreted; half-lives of chemicals in water are therefore considerably reduced (Balk & Ford, 
1999). However, the octanol-water coefficients of the selected PCPs suggest a high 
potential for bioaccumulation in aquatic organisms, especially for polycyclic musks 
(PubChem, 2014); overview of physico-chemical properties in Table 1. This kind of 
behavior makes it difficult to predict the residence time of PCPs in aquatic ecosystems. 
Based on their vapor pressure, water solubility and consequently the estimated Henry’s 
Law constant, polycyclic musks are expected to volatilize from surface waters (PubChem, 
2014). However, polycyclic musks are also expected to precipitate to the bottom of the 
sea and adsorb to suspended solids and sediments, which in turn attenuates volatilization 
from water and increases chemicals half-lives (PubChem, 2014). Diethyl phthalate is not 
expected to volatilize from surface waters but adsorption to suspended solids and 
sediments seems to be an important fate process (PubChem, 2014). Contrary to the 
polycyclic musks, DEP is expected to hydrolyze (slowly) in the environment and 
biodegradation in the aquatic environment seems to play a major role (PubChem, 2014). 
Previous findings indicate that polycyclic musks accumulate in mussels, crustaceans, fish 
and even in organisms at higher trophic levels, including coastal birds and mammals in 
marine ecosystems (Nakata et al., 2007; Ramirez et al., 2009). Taking this into 
consideration, bioaccumulation can occur through direct contact with the water and the 
contaminated seabed and/or through food chain transfer. The latter one makes benthic 
organisms more susceptible to exposure to PCPs (Nakata et al., 2007). Another important 
factor that influences the presence of PCPs in organisms is their lipid content. 
Compounds which do not possess ionizable functional groups, such as polycyclic musks, 
have a positive correlation with tissue lipid content (Ramirez et al., 2009). As known, 
hydrophobic compounds concentrate more easily in tissues with high lipid content, such 
as the liver. This was confirmed by a national pilot study conducted by Ramirez et al. 
(2009) in the United States, where different fish species were screened for the presence 
of PPCPs in their tissues and the results showed that higher concentration and 
frequencies of compounds are detected in livers in comparison with fillets. AHTN and 
HHCB were detected in fish from all the five rivers, with maximum concentrations ranging 
from 21–290 ng/g and 300–2100 ng/g, respectively (Ramirez et al., 2009). In trout from 
Danish fish farms, lower concentrations of polycyclic musks were detected: 2.24–2.70 
ng/g fresh weight for AHTN and 5.87–8.54 ng/g fresh weight for HHCB (Duedahl-Olesen 
et al., 2005). According to Brausch & Rand (2011), polycyclic musks are found in 
European rivers at concentrations ranging between 2–300 ng/L, with HHCB being 
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detected at the higher levels. Regarding the environmental concentrations of DEP, a study 
conducted in India revealed that this phthalate is present along the river Kaveri with a 
mean level of 241 ng/L (Selvaraj et al., 2014). This value is similar to the concentrations 
detected in European rivers of Spain and Sweden which range between 10–280 ng/L. 
However, in surface waters from the Netherlands, DEP was detected at much higher 
levels, reaching values of 2300 ng/L (Vethaak et al., 2005). In sediments from these rivers 
was verified the same tendency; in India DEP was present at a mean level of 16.5 ng/g 
and in the Netherlands at concentrations ranging between 65–1200 ng/g dry weight 
(Selvaraj et al., 2014; Vethaak et al., 2005). In muscle tissue of estuarine and freshwater 
fish, DEP was detected at concentration ranges of 6.7–91 ng/g wet weight in flounder and 
22–321 ng/g wet weight in bream (Vethaak et al., 2005).  
Table 1. Identification and physico-chemical properties of three widely used personal care products 
(AHTN: tonalide; HHCB: galaxolide; DEP: diethyl phthalate; from PubChem, 2014). 
 
AHTN HHCB DEP 
Molecular formula C18H26O C18H26O C12H14O4 
IUPAC name 
1-(3,5,5,6,8,8-
hexamethyl-6,7-
dihydronaphthale
n-2-yl)ethanone 
4,6,6,7,8,8-
hexamethyl-1,3,4,7-
tetrahydrocyclopent
a[g]isochromene 
Diethyl 
benzene-1,2-
dicarboxylate 
Structural formula 
 
 
 
Molecular weight (g/mol) 258.4 258.4 222.24 
Physical state solid viscous liquid oily liquid 
Solubility in water (mg/L) 1.25 1.75 1080 
Octanol/Water Partition Coefficient           
(log Kow) 
5.7 5.9 2.47 
Vapor pressure (mm Hg) 5.12 × 10
-4
 5.45 × 10
-4
 2.1 × 10
-3
 
Henry's law constant (atm-cu m/mol) 1.393 × 10
-4
 1.32 × 10
-4
 6.10 × 10
-7
 
 
1.2. Toxicity testing 
In toxicological testing, the potential adverse effects of chemicals on living systems and 
the mechanisms of toxicity involved are assessed. For this purpose, intact animals or cell 
cultures can be used in a diversity of in vivo and in vitro tests. To establish a dose-
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response relationship, selected concentration ranges of chemicals are used (Robinson & 
Thorn, 2005). Typically, toxicity tests use whole animals that are exposed to high doses of 
the chemical to be tested. However, alternatives to these methods have been developed 
to enable faster screening of chemicals and reduce and/or replace the use of laboratory 
animals. An increasing number of cells, cellular components and tissues have been used 
to evaluate the effects of chemicals on a molecular level. The use of in vitro model 
systems allows a better understanding of the cellular response pathways that may lead to 
adverse health effects on living organisms (National Research Council, 2007). 
Furthermore, this system reduces the quantity of chemicals needed for testing and the 
costs associated with the maintenance of animals (Soldatow et al., 2013). 
1.2.1. In vivo experimental models  
Experimental model organisms are non-human species used for research purposes to 
investigate a specific biological process or system. These experimental organisms can be 
used to understand a number of phenomena that occur in the environment through more 
simplified in vivo models. It is important to take into account that data obtained from less 
developed organisms can be a useful tool to predict behavior of chemicals in similar 
species or more distant and complex organisms. In general, experimental model 
organisms are easy to breed and maintain on a large scale under laboratory conditions 
and can be considered mediators between theory and reality (Ankeny & Leonelli, 2011). 
An experimental model can be chosen according to their biochemical and physiological 
functions and ecological relevance. Fish are relevant species for environmental monitoring 
studies due to their role in the aquatic trophic chain and similarity to higher vertebrates, in 
terms of responses to toxic substances. Fish represents an extremely diverse and large 
group of vertebrates that have the ability to adapt to a wide range of environments (Harris 
et al., 2014). As good models for environmental biology studies they might serve as first 
insight into the presence of xenobiotics in the environment. One of the most common 
representatives of coldwater species used in fish research is rainbow trout, Oncorhynchus 
mykiss (Ostrander, 2000).  
1.2.2. In vitro models: cell cultures 
Although in vivo models resemble more what happens in a natural environment and the 
complex biological processes and interactions that occur during exposure of organisms to 
xenobiotics, in vitro models have been increasingly used in toxicological studies 
(Ostrander, 2000). It is important to evaluate the potential effects of chemicals starting 
from a cellular and molecular level, which is possible through the use of in vitro models. In 
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this way, chemicals can be screened more quickly and easily for its mechanism of action. 
This can be done by using fish cell cultures prepared from different tissues and organs. 
The term cell culture can be applied to two different types of cultures: primary cultures and 
cell lines. Primary cultures are cells obtained directly from the fish and maintained under 
in vitro conditions whereas cell lines are cultures obtained from the subculturing or 
passaging of primary cultures (Ostrander, 2000). Primary cultures mimic more closely the 
function and physiological state of cells in vivo than cell lines and are widely used models 
in the field of (eco)toxicology (Ostrander, 2000). Good examples are the primary fish 
hepatocyte cultures, important to assess metabolic activity and mechanisms of toxicity in 
vitro (Schreer et al., 2005). The liver is an organ of extreme importance in vertebrates for 
being crucial in the maintenance of internal homeostasis and being the major site of 
metabolism; therefore widely used in toxicity testing (Segner, 1998). Primary hepatocyte 
cultures are useful tools for enzyme induction and inhibition studies since they are able to 
maintain functional activities for 24–72 hours (Soldatow et al., 2013). However, some cell 
culture conditions should be fulfilled to maintain viable cells for an extended period of time 
and preserve the functional properties of cells. In primary cultures of fish cells, attention 
should be given to adjustments in parameters such as temperature, osmolality, pH and 
CO2 partial pressure (Hodne et al., 2012). 
1.2.3. Cytotoxicity testing 
To evaluate the effects of chemicals on the viability of cells is a widely used method. 
Therefore, the number of metabolically active cells in culture is measured; cells are 
exposed to a metabolic indicator that interacts with cellular enzymes and consequently is 
converted into a measurable fluorescent or luminescent compound (Stoddart, 2011). For 
instance, once the non-fluorescent dye resazurin enters in contact with viable cells it is 
reduced into the fluorescent compound resorufin (Stoddart, 2011). Through the use of 
cytotoxicity assays it is possible to better understand the mode of action of chemicals. For 
instance, when cells become unviable, gene expression can be affected (Schreer et al., 
2005). Polycyclic musks are potential inducers of cytotoxic effects on rainbow trout cells. 
Schnell et al. (2009) monitored cell viability on RTL-W1 liver cells exposed to polycyclic 
musks by using two fluorescent dyes (AB and CFDA-AM) and concluded that these are 
cytotoxic to a fish liver cell line, specially tonalide. This is consistent with findings from 
Randelli et al. (2011), which suggest that tonalide could be a potential inducer of early 
apoptosis and is capable of affecting gene expression in rainbow trout. However, 
information about the toxicological mechanisms of action of PCPs on fish primary cell 
cultures is limited.  
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1.3. Cellular detoxification system 
Metabolism of xenobiotics occurs through successive reaction within cells. This 
biotransformation process aims to decrease toxicity of xenobiotics and generate 
compounds that are easier to eliminate. However, the toxicity of certain compounds can 
be increased when more reactive metabolites are generated. Phase I and phase II 
enzymes, that predominate in the liver, are responsible for the metabolism of xenobiotics. 
Phase I enzymes have the ability to transform lipophilic xenobiotics in more polar 
metabolites and provide sites for conjugation reactions (Hodgson, 2010). Phase II 
enzymes are involved in the conjugation of these xenobiotic metabolites with endogenous 
metabolites, including glutathione (GSH), sugars and amino acids (Hodgson, 2010). One 
example of phase II enzyme is glutathione S-transferase (GST), which conjugates GSH 
with compounds containing electrophilic centers (Croom, 2012). GSH is important in the 
cellular defense against agents that cause oxidative stress because it removes reactive 
electrophiles and therefore protects cells from the action of radicals via the glutathione 
redox cycle; general oxidative stress process in Figure 1. Oxidative stress results from 
the imbalance between production of reactive oxygen species (ROS) and its 
decomposition through antioxidant defense mechanisms (Chen et al., 2012). In the 
presence of an excessive amount of ROS, e.g. superoxide anion (
•
O2
–) and hydrogen 
peroxide (H2O2), cells enter oxidative stress processes (Di Giulio & Newman, 2013). The 
GSH-dependent antioxidant defense mechanism is of great importance in the cell 
defenses against adverse effects of ROS; enzymes such as glutathione peroxidase (GPx) 
and glutathione reductase (GR) play a major role (Zhang, 2014). Interaction of xenobiotics 
with the electron transport chain may generate •O2
– and consequently H2O2, which are 
cleared through the action of enzymes such as glutathione peroxidase (Di Giulio & 
Newman, 2013; Zhang, 2014). In the absence of stress, cells contain a high intracellular 
ratio of reduced glutathione (GSH) to oxidized glutathione (GSSG; Hodgson, 2010). Once 
metabolism of xenobiotics is over, compounds resulting from this process need to be 
eliminated. This is possible through passive transport (diffusion of molecules across 
cellular membranes) or active transport with the intervention of transporter proteins. These 
proteins require energy to transport the compounds against the concentration gradient 
(Croom, 2012). 
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Figure 1. Overview of oxidative stress induced by mechanisms such as redox cycling of 
xenobiotics (parent compound) and subsequent formation of reactive oxygen species (adapted 
from Di Giulio & Newman, 2013). 
 
1.3.1. ABC transporters 
ATP-binding cassette (ABC) transporters are a large family of proteins that have been 
conserved across the animal kingdoms and can be found in all species from bacteria to 
man (Higgins, 2001). These proteins are an integral part of the cellular detoxification 
system and are mostly involved in the translocation of endogenous and exogenous 
substances across the membrane, including the excretion of chemicals from the cell 
through efflux pumps (Choi, 2005). ABC transporters use the hydrolysis of ATP to pump 
non-polar compounds from the membrane bilayer out of the cell, including xenobiotics 
(Choi, 2005). These transporters are composed of four main domains: two 
transmembrane domains (TMDs) and two hydrophilic nucleotide-binding domains (NBDs; 
also known as ABC domains) that face the cytoplasm; schematic representation in Figure 
2. The domains can be encoded as single polypeptides or be fused in any possible 
combination (Higgins, 2001). Mammalian and fish ABC genes are organized in 
subfamilies categorized from ABCA to ABCH; the latter one is exclusively for fish (Lončar 
et al., 2010). Despite the existence of numerous ABC proteins, P-glycoproteins (Pgp; 
ABCB1) and multidrug resistance-associated proteins 1–5 (MRP1–5; ABCC1–5) revealed 
to be among the toxicologically most relevant proteins in mammalian tissues; they 
possess MXR-related functions (Lončar et al., 2010; Faria et al., 2011). ABC proteins are 
present in aquatic organisms inclusive in mussels, sea urchin, sea star and rainbow trout 
tissues (liver, kidney, intestine, gonads, brain; Lončar et al., 2010; Faria et al., 2011). 
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Several subfamilies of transporters are expressed in these tissues: in liver, high 
expression of ABCB1, ABCB11 and ABCC2 were detected (Lončar et al., 2010). 
According to Zaja et al. (2008), primary trout hepatocytes also express components of the 
detoxification system, including phase I and II enzymes and ABC proteins.  
 
 
Figure 2. Models of the open and closed structure of ABC transporters (TMDs, transmembrane 
domains; NBDs, nucleotide-binding domains; adapted from: Cuthbertson et al., 2010). 
 
1.3.2. Multixenobiotic resistance  
In aquatic organisms, the defense mechanism associated with the functioning of the ABC 
transporters against xenobiotics is known as multixenobiotic resistance (MXR; Zaja et al., 
2008). Although ABC transporters are specific for its substrate(s), it should be noted that 
these proteins transport a wide spectrum of substances and that xenobiotics entering the 
cell can bind to the ABC proteins and consequently inhibit their function (Higgins, 2001). 
Thus, xenobiotics normally effluxed by ABC transporters are retained and accumulated in 
the cells leading to higher toxicity levels (Smital et al., 2004). Innumerous inhibitors of the 
MXR defense system are present in the environment, making organisms more susceptible 
to exposure to potentially toxic substances. For this reason, MXR inhibitors are 
considered chemosensitizers; they will increase chemosensitivity of organisms towards 
xenobiotics present in their environment (Smital et al., 2004). Chemosensitizers can be 
divided into two groups based on their mechanism of action: competitive inhibitors and 
non-competitive inhibitors (Faria et al., 2011). The first act as substrates with high affinity 
for ABC protein binding sites, saturating the substrate-binding capacity of transporters, 
thus preventing the binding and transport of other substances (Smital et al., 2004; Faria et 
al., 2011). Examples of competitive inhibitors are verapamil and MK571 (Smital et al., 
2004; Keppler, 2011). Non-competitive inhibitors can act in different ways e.g., they can 
block the ATPase activity of transporters necessary for its proper functioning (Smital et al., 
2004). Examples of xenobiotics that have a MXR inhibitory potential in aquatic organisms 
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are the polycyclic musks (Smital et al., 2004). Luckenbach & Epel (2005) showed that 
these compounds inhibit the activity of ABC efflux transporters in gills of the marine 
mussel Mytilus californianus. Despite the progresses in this field, knowledge about the 
interference of chemicals with ABC transporters in fish remains scarce; it is therefore of 
major importance to consider indirect effects of PCPs on aquatic organisms. 
1.4. Mixture toxicity  
In risk assessment, chemicals are mostly evaluated as single substances. In the first 
instance, assessing the effect of single compounds can be sufficient to establish 
thresholds below which each chemical can be allowed to be used. However, 
environmental contamination is a consequence of the release of innumerous chemicals 
from various sources, resulting in complex mixtures of chemicals that need to be 
assessed (Cedergreen et al., 2008). Mixtures of chemicals sometimes induce greater 
biological effects on organisms and in concentration ranges where single chemicals do 
not show effects (Thorpe et al., 2006; Baas et al., 2010). Considering this, it is important 
to predict combined effects of chemical mixtures, which is sometimes possible through 
exploitation of single-substance toxicity data (Cedergreen et al., 2008). Mathematical 
modeling has been seen as a suitable tool to relate chemicals present in the environment 
at a given concentration to a predicted biological effect (Thorpe et al., 2006). In binary 
mixtures, if the effects of single compounds and respective concentrations in the mixture 
are known, the most frequently used models to predict joint effects in ecotoxicology are 
the concentration addition (CA; also known as Loewe additivity) model and the 
independent action (IA; also known as Bliss independence) model (Backhaus & Faust, 
2012; Cedergreen et al., 2008). CA assumes that chemicals have a similar mechanism of 
action, which means, for example, that they bind to the same receptor and therefore can 
be considered as dilutions of one another (Backhaus & Faust, 2012; Cedergreen et al., 
2007). In turn, IA assumes that chemicals have a dissimilar mechanism of action. 
Experimental results can easily be compared to these reference models, in order to 
evaluate the joint effects of chemicals. If the effect of a mixture and respective CA model 
predictions are similar, chemicals are said to be additive (Cedergreen et al., 2007). 
However, when the effect of a mixture differs significantly from the model predictions, it 
means that interactions occur, which either can be synergistic or antagonistic (Baas et al., 
2010; Cedergreen et al., 2007). If the joint effect of two chemicals gives a higher effect 
than the model prediction, the effect is said to be synergistic. If the opposite occurs, the 
effect of the chemicals is said to be antagonistic (Cedergreen et al., 2007). CA is 
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considered the best and more conservative reference model for chemical mixtures with 
similar target sites (Cedergreen et al., 2008). 
1.5. Aims and hypotheses  
The central objective of the present study was to evaluate the toxicity of three PCPs 
(AHTN, HHCB and DEP), alone and in binary mixtures, to O. mykiss hepatocytes. The 
following hypotheses were tested: 
 
1) Exposure to PCPs causes a dose-dependent cytotoxic effect on O. mykiss 
hepatocytes; 
 
2) There is a dose-dependent decrease in ABC transporter activity of O. mykiss 
hepatocytes after exposure to single PCPs; 
 
3) Toxicological interactions with effects on hepatocytes ABC transporter activity occur 
under hepatocyte exposure to binary mixtures of the tested PCPs. 
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2. Material and Methods 
2.1. Chemicals  
Polycyclic musks 6-acetyl-1,1,2,4,4,7-hexamethyltetralin (AHTN) and 1,3,4,6,7,8-
hexahydro-4,6,6,7,8,8-hexamethylcyclopenta-[g]-2-benzopyran (HHCB) solution, as well 
as diethyl phthalate, monochlorobimane (mBCl) and verapamil hydrochloride were 
purchased from Sigma-Aldrich (Schnelldorf, Germany). Alamar blue (AB) and 5-
carboxyfluorescein diacetate actetoxymethyl ester (CFDA-AM) were obtained from 
Invitrogen Life Technologies (Paisley, Scotland). MK571 and rhodamine 123 were 
obtained from Cayman Chemical (Ann Arbor, Michigan, USA) and Molecular Probes 
(Paisley, Scotland), respectively. The chemicals used throughout the experiment are 
listened in detail in Table 10, Appendix I.  
2.2. Test organism 
Juvenile Oncorhynchus mykiss (body length, 20–30 cm) were obtained from a local fish 
farm (Ås, Akershus) and kept in tanks at the Department of Biology, University of Oslo. 
Water conditions were maintained at 7–8 °C, pH 7, with approximately 100% oxygen 
saturation. The light was adjusted to a day/night cycle of 12/12 h. Rainbow trout were fed 
once a day with Spirit Ørret 300 (4.5 mm) fish pellets (Skretting Averøy, Averøy, Norway). 
2.3. Primary cell culture 
2.3.1. Hepatocytes isolation 
O. mykiss hepatocytes were isolated according to the perfusion technique described by 
Ellesat et al. (2010). This procedure required a perfusion buffer (Table 11, Appendix I) 
that was previously prepared and kept at 4 °C. Fish were sacrificed with a blow to the 
head and the body surface was disinfected by using 70% ethanol. The body cavity was 
carefully opened from the urogenital pore to the pectoral fin to access the portal vein, liver 
and heart, without damaging the organs. A cannula was inserted into the portal vein that 
leads to the liver and perfusion buffer, containing EGTA (26 µM), was used to initially 
perfuse the liver. After a few seconds, the liver obtained a lighter colour and the heart was 
opened to allow the outflow of blood. This perfusion buffer was used during 10–15 min, 
until the liver has reached a yellow appearance and was without blood. Sometimes it was 
necessary to gently massage the liver to allow better clearance from blood or to remove 
blood clots that were impeding the outflow of blood from the heart. For the digestion, the 
liver was perfused (10–15 min) with the perfusion buffer containing 0.3 mg/mL 
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collagenase VIII and CaCl2 (2 mM). After removing the cannula, the digested liver was 
transferred into a glass tray and gently mixed (10 min) in ice-cold perfusion buffer 
containing 0.1% (w/v) BSA, to separate the cells. The cell suspension was filtered through 
sterile 200 µm and 100 µm nylon meshes (Bigman AB, Sundbyberg, Sweden). Filtered 
liver cells were centrifuged three times at 500 rpm (27× g) for 3–4 min at 4 °C, using an 
Eppendorf 5810R Centrifuge (Eppendorf, Hamburg, Germany). The supernatant was 
discarded and the hepatocytes were re-suspended in perfusion buffer containing BSA. 
After the last centrifugation, the hepatocytes were re-suspended in sterile filtered (0.22 
µm) Leibovitz's L-15 medium (pH 7.6, 310 mOsm) with 0.3 mg/mL L-glutamine. Sodium 
bicarbonate solution (4.5 mM) and an antibiotic antimycotic mix (100×) were added to 
reach a final concentration of penicillin, streptomycin and amphotericin B of 100 U/mL, 
100 µg/mL and 0.25 µg/mL, respectively. The cells were filtered once more through a 
sterile 100 µm nylon mesh and kept on ice. To improve the quality of the cultures and 
reduce certain stress factors, osmolality of the medium and working solutions were 
adjusted to the plasma osmolality of rainbow trout (310 mOsm) with Knauer Osmometer 
Automatic (Knauer, Berlin, Germany; Al-Jandal & Wilson, 2011; Hodne et al., 2012). All 
glassware and instruments were autoclaved before use. 
2.3.2. Cell viability 
To determine the number of viable cells, the trypan blue exclusion assay was used 
(Stoddart, 2011). This assay is based on the dye exclusion capability of living cells, since 
they possess intact cell membranes. Thus, viable cells are easy to detect due to their 
clear cytoplasm and dead cells are detectable by their blue stained cytoplasm, since these 
cells take up the dye. Cells were diluted 1:3 in trypan blue and counted in a Bürker-Türk 
counting chamber. Exposure of cells to trypan blue should not exceed 15 min because 
also viable cells may start to take up the dye (Frei, 2011). An area of 0.064 mm2 was 
counted four times and the average value of viable cells was used in the following 
formula, in order to obtain number of cells/mL:  
 
𝑐𝑒𝑙𝑙𝑠 𝑚𝐿⁄  =  
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠
𝑐𝑜𝑢𝑛𝑡𝑒𝑑 𝑎𝑟𝑒𝑎 (𝑚𝑚2) × 𝑐ℎ𝑎𝑚𝑏𝑒𝑟 𝑑𝑒𝑝𝑡ℎ (𝑚𝑚) × 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛
 × 1000 
 
Cells were only used for experiments if the viability was larger than 85%. The amount of 
collected cells was sufficient to meet the required volume (~200 mL) for each 
experimental replicate; measured parameters of each fish replicate and respective cell 
viability in Table 2. 
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Table 2. Parameters (body weight and body length) of Oncorhynchus mykiss replicates and 
respective number of isolated and viable cells after hepatocyte isolation. 
 
Body weight 
(g) 
Body length 
(cm) 
Number of isolated cells 
(cells/mL) 
Cell viability 
(%) 
O. mykiss 1 216 26.5 4.9 × 10
6
 89 
O. mykiss 2 228 28.4 5.5 × 10
6
 85 
O. mykiss 3 189 27.5 3.9 × 10
6
 92 
 
2.3.3. Cell culture conditions 
The cells were diluted to 0.5 × 106 cells/mL and seeded on 96-well Primaria® plates 
(Falcon, BD Biosciences, San Jose, California, USA) to improve cell attachment in the 
wells. Final density of the cells was 0.1 million cells/200 µL (corresponding to the volume 
of a well). The isolated hepatocytes were incubated at 15 °C and retention of cells was 
observed by microscopy (Olympus CKX41 microscope, Olympus, Hamburg, Germany). 
2.4. Exposure of hepatocytes to PCPs 
2.4.1. General exposure conditions 
Isolated hepatocytes were maintained in culture medium for two days. After 24 h of 
incubation half of the medium was carefully replaced by new medium, to avoid 
detachment of the cells from the bottom. The medium with L-glutamine used throughout 
this procedure was only supplemented with sodium bicarbonate solution (4.5 mM), in 
order to reduce possible background effects caused by the presence of antibiotics in the 
culture medium. AHTN, HHCB and DEP were dissolved in 5% DMSO and aliquots were 
stored at –22 °C. Stock solutions of VER and MK571 (dissolved in 2% DMSO) and 
Rho123 (dissolved in 10% DMSO) were prepared in Milli-Q water and stored at –22 °C. 
These aliquots were thawed directly before use and diluted in L-15 medium until the 
desired concentrations were reached. The obtained dilutions were adjusted by adding 
DMSO, to have the same concentration of solvent in each sample. For VER, MK571 and 
Rho123 the final concentration of DMSO in culture medium was 0.1% (v/v).  
2.4.2. Single exposure 
To determine the effect of single compounds, hepatocytes were exposed to PCPs 
separately. After 24 h of incubation, half of the medium from the plates designed for PCPs 
exposure was replaced by medium containing different concentrations of AHTN and 
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HHCB (0.02, 0.2, 2.3, 23.3, 200 and 1000 µM) and DEP (2.3, 23.3, 232.8, 2328, 20000 
and 100000 µM), whereas half of the medium from the plates designed for inhibitor 
standard curves was replaced by new culture medium (plate design on Figure 11, 
Appendix I). Plates were incubated with the test compounds for 24 h to determine ABC 
transporter activity and cytotoxicity. The concentration of DMSO in culture medium was 
0.5% (v/v). DMSO was included as a solvent with control cells. A total of three replicates 
were done. 
2.4.3. Mixture exposure 
The effect of a mixture of PCPs was determined by exposing hepatocytes to a 
combination of two of the compounds previously used; PCPs solutions were prepared 
separately and posteriorly mixed inside the well. After 24 h of incubation, half of the 
medium was replaced by medium containing a mixture of AHTN and HHCB (0.06, 0.56, 
5.6, 56, 100 and 1000 µM of each musk) and a mixture of HHCB (0.06, 0.56, 5.6, 56, 100 
and 1000 µM) and DEP (5.6, 56, 557, 5571, 10000 and 100000 µM); plate design on 
Figure 12, Appendix I. Plates were incubated for 24 h to determine ABC transporter 
activity. The concentration of DMSO in culture medium was 1% (v/v). DMSO was included 
as a solvent with control cells. A total of three replicates were done. 
2.5. Cytotoxicity testing 
Fluorescent dyes were used as a non-invasive method to evaluate cell viability of primary 
hepatocyte cultures. Schreer et al. (2005) described the combined AB/CFDA-AM assay as 
a suitable tool for in vitro measurements of cell viability in primary rainbow trout 
hepatocytes. This method, together with mBCl, was also successfully used on plaice, long 
rough dab and Atlantic cod primary hepatocytes (Ellesat et al., 2011). Therefore, AB, 
CFDA-AM and mBCl were used as a measure of cell metabolic activity, cell membrane 
integrity and amount of reduced glutathione (GSH), respectively. In living cells, AB is 
reduced by mitochondrial reductases into resorufin, a water soluble and fluorescent dye; 
its presence represents a functional metabolic activity. In case of an impaired metabolic 
activity, the amount of resorufin in the cells decreases, which results in lower fluorescence 
levels. CFDA-AM, a membrane permeable, apolar and non-fluorescent dye, is hydrolysed 
by cytosolic esterases into 5-carboxyfluorescein (CF), a polar fluorescent dye. CF is 
retained in the cells, which allows the measurement of cell membrane integrity. When 
enzymatic activity is compromised, the amount of CF in the cells decreases leading to 
lower fluorescence levels; this represents a loss of membrane integrity. mBCl enters cells 
and forms a fluorescent adduct with the water soluble substrate GSH, which is a product 
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of cell defense against reactive oxygen species. This reaction is considered a 
measurement of oxidative stress and it is catalyzed by glutathione S-transferase (GST; 
Kamencic et al., 2010). The measured fluorescence reflects the GSH content; 
fluorescence will be greater the more GSH is present in the cells. The cytotoxicity 
measurements were performed according to the protocol described by Ellesat et al. 
(2011). All medium was removed from the cell cultures and replaced by 100 µL of Tris-
buffer (Table 11, Appendix I) containing 5% AB, 4 µM CFDA-AM and 275 µM mBCl. Cells 
were incubated in the dark for 30 min on an orbital shaker at room temperature. 
Fluorescence was measured at excitation/emission wavelengths of 530 nm/590 nm (AB), 
485 nm/530 nm (CFDA-AM) and 360 nm/460 nm (mBCl) with a Synergy Mx microplate 
reader (BioTek Instruments, Winooski, Vermont, USA). These measurements could be 
done simultaneously since the fluorescent probes can be detected at different wavelength 
pairs. Sensitivity of the instrument was set to 80%. To measure autofluorescence of 
untreated hepatocytes, the cells were maintained in culture medium alone. CFDA-AM (4 
mM) and mBCl (50 mM) stock solutions were prepared in DMSO and stored at –22 °C.  
2.6. ABC transporter activity 
The transporter activities in Oncorhynchus mykiss hepatocytes were determined by using 
the fluorescent ABC transporter substrate rhodamine 123. The inhibitory potential of PCPs 
was compared with the inhibitory effect of the transporter inhibitors MK571 (which mainly 
targets ABCC transporters) and VER (general inhibitor, but thought to inhibit ABCB1; 
Faria et al., 2011). Based on the findings of Zaja et al. (2008) and Ferreira et al. (2014), 
increasing concentrations (0.1, 0.3, 1.7, 8.5, 10 and 50 µM) of the inhibitors MK571 and 
VER were selected to perform standard curves. After 48 h of incubation, half of the culture 
medium (100 µL) was removed and 50 µL of medium containing the model inhibitors 
MK571 and VER was added. Hepatocytes were incubated for 5 min at room temperature. 
After this pre-incubation period, 50 µL of medium containing the model substrate Rho123 
was added to the wells. From the wells containing cells previously exposed to PCPs, only 
50 µL of culture medium was removed and replaced by medium containing the substrate 
Rho123. Final concentration of Rho123 was 1 µM. The cells were incubated in the dark 
for 2 h on an orbital shaker at room temperature. After the incubation period the cells were 
washed with 200 µL sterile PBS (pH 7.4, 310 mOsm). Cells were lysed by adding 200 µL 
of 0.5% Triton X-100 in PBS and subjecting them to three shaking cycles of 2 s. The 
accumulation level of Rho123 in the cells, which is detected by its fluorescence, can be 
related to the ABC transporter activity (Smital et al., 2003). In the case of inhibition of 
transporter activity, increased levels of Rho123 will be accumulated in the cells and 
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fluorescence will be higher. Fluorescence was measured at 485 nm excitation and 538 nm 
emission with a Synergy Mx microplate reader (BioTek Instruments). Sensitivity of the 
instrument was set to 80%. The autofluorescence of untreated hepatocytes was 
measured to be used as blank.  
2.7. Data analysis 
Experiments were conducted with three fish replicates, i.e. three primary cell cultures 
were performed using one fish for each. As shown in the plate design (Figure 11 and 
Figure 12, Appendix I), each treatment group consists of eight pseudo-replicates. Thus, 
final number of pseudo-replicates for each concentration of PCPs and inhibitors equals 
twenty-four. Data were plotted in a x,y graph using GraphPad Prism 6.04 (GraphPad 
Software, San Diego, California, USA). For the cytotoxicity assays and MXR inhibitors, 
data were standardized relative to control (average value). When analyzing ABC 
transporter activity of PCPs, data were standardized relative to the lowest and highest 
effect concentration (average value) of the inhibitor MK571. Experimental replicates were 
standardized separately. The obtained values were expressed in percentages and plotted 
against the logarithm of agonist concentration. The non-linear regression curve fit applied 
was a sigmoidal (four-parameter logistic) dose-response curve with the bottom and top 
values set at 0 and 100, respectively. The ABC transporter activity data obtained was 
further used for model prediction calculations. CA predictions of binary mixtures of PCPs 
were calculated as,  
𝐶𝑚𝑖𝑥 =  ( 
𝑝1
𝑐1
+ 
𝑝2
𝑐2
 )
−1
 
, where 𝐶𝑚𝑖𝑥 represents the concentration of the mixture, derived from the individual 
concentrations 𝑐1 and 𝑐2 and respective proportions 𝑝1 and 𝑝2 of the total concentration 
(Thorpe et al., 2006). Total concentration means the sum of 𝑐1 and 𝑐2, i.e. the combined 
concentration of single substance 1 and 2 given a certain effect. These values were 
obtained through the dose-response curve by constraining the curve fit to different F 
values, corresponding to EC10, EC20, etc., with a total of 13 steps. IA predictions were 
calculated as, 
𝐸𝑚𝑖𝑥  = 1 − ((1 − 𝑒1)(1 − 𝑒2)) 
, where 𝐸𝑚𝑖𝑥 represents the percentile effect of the mixture, derived from the individual 
percentile effects 𝑒1 and 𝑒2 (Hadrup et al., 2013). 𝐸𝑚𝑖𝑥 is represented as function of the 
combined concentration of substance 1 and 2. Statistical comparisons of EC50 values for 
18 
 
mixture toxicity were performed using the extra sum-of-squares F test with an α error of 
0.05. Results are expressed as mean ± standard deviation (SD) with confidence intervals 
(CI) established at 95%. 
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3. Results 
3.1. Cytotoxicity testing 
The effects of PCPs are presented as dose-response curves and were quantitatively 
estimated as concentrations able to cause effect on 50% of the exposed cells (EC50; 
effective concentration). The data included in this analysis corresponds to two 
experimental replicates (n = 2, which means 16 pseudo-replicates), since the dose-
response curves obtained for the last primary cell culture deviated from the dose-
response relationships of the other two replicates, leading to inconclusive results. The 
measured fluorescence of hepatocytes exposed to the solvent control DMSO was higher 
than for hepatocytes used as blank, suggesting a negative impact of DMSO on cell 
viability. In the data analysis, comparison of the exposure groups to the control group was 
done. Therefore, direct reference to the toxic effect of DMSO is not considered relevant. 
All individual experimental replicates can be found in Appendix II. 
3.1.1. Cell metabolic activity 
The metabolic function of the mitochondria after 24 h of exposure of hepatocytes to PCPs 
is summarized in Figure 3 and Table 3. The generated dose-response curves are 
sigmoidal and possess descending slopes. AHTN and DEP only started to show effect at 
200 × 10-6 M and 20 × 10-3 M, respectively; these concentrations are extremely close to 
their EC50 values. Mitochondrial activity of hepatocytes exposed to HHCB was reduced at 
concentrations starting from 2.3 × 10-6 M and impairment of the metabolic function of 50% 
of the cells was observed at 4.71 × 10-6 M.  
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Table 3. Personal care products EC50 values and respective 95% confidence interval for 
mitochondrial activity of hepatocytes, derived from a non-linear regression curve fit. 
 
AHTN HHCB DEP 
r
2
 0.889 0.941 0.856 
EC50 (M) 237.6 × 10
-6
 4.71 × 10
-6
 ~ 25.40 × 10
-3
 
EC50 95% CI (M) 119.6–472.0 × 10
-6
 1.89–11.73 × 10
-6
 – 
 
3.1.2. Cell membrane integrity 
The membrane integrity of hepatocytes after 24 h of exposure to PCPs is summarized in 
Figure 4 and Table 4. The dose-response curves are sigmoidal for all PCPs, with a 
gradually decreasing slope for AHTN and HHCB. AHTN affected membrane integrity of 
cells at lower concentrations than mitochondrial activity; the effects were evident at 
(A) (B) 
(C) (D) 
Figure 3. Mitochondrial activity of hepatocytes exposed to (A) AHTN, (B) HHCB, (C) DEP and (D) 
comparison of these three PCPs (% of control; mean ± standard deviation; n = 2; dotted lines: 95% 
confidence interval; C: control). 
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concentrations greater than 2.3 × 10-6 M and the EC50 value is approximately two times 
lower (111.40 × 10-6). HHCB has a slightly lower EC50 for membrane integrity than for 
mitochondrial activity. However, higher concentrations of AHTN and HHCB are necessary 
to affect the membrane integrity of 100% of the cells. DEP seems to affect mitochondrial 
and membrane integrity of hepatocytes in a similar way, tending to induce effects on 
membrane integrity at lower concentrations. 
 
 
Table 4. Personal care products EC50 values and respective 95% confidence interval for 
membrane integrity of hepatocytes, derived from a non-linear regression curve fit. 
 
AHTN HHCB DEP 
r
2
 0.679 0.853 0.811 
EC50 (M) 111.40 × 10
-6
 3.67 × 10
-6
 25.31 × 10
-3
 
EC50 95% CI (M) 68.69–180.60 × 10
-6
 2.57–5.23 × 10
-6
 7.32–87.48 × 10
-3
 
(A) (B) 
(C) (D) 
Figure 4. Membrane integrity of hepatocytes exposed to (A) AHTN, (B) HHCB, (C) DEP and (D) 
comparison of these three PCPs (% of control; mean ± standard deviation; n = 2; dotted lines: 95% 
confidence interval; C: control). 
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3.1.3. Oxidative stress 
The GSH content of hepatocytes after 24 h of exposure to PCPs is summarized in Figure 
5 and Table 5. There are non-sigmoidal dose-response curves with exception of HHCB, 
which shows a dose dependent increase in GSH content at concentrations ranging 
between 0.02–2.3 × 10-6 M. In general, the GSH content of hepatocytes increased as the 
concentration increased. However, at higher PCPs concentrations, the oxidative stress 
seemed to increase so much that the GSH content of hepatocytes collapsed. The 
concentrations of PCPs presented in red were excluded from the non-linear regression 
curve fit, since they represent unviable cells and cannot be considered for this parameter. 
 
 
 
(A) (B) 
(C) (D) 
Figure 5. GSH content of hepatocytes exposed to (A) AHTN, (B) HHCB, (C) DEP and (D) 
comparison of these three PCPs (% of control; mean ± standard deviation; n = 2; dotted lines: 95% 
confidence interval; C: control; red error bars: concentrations excluded from the non-linear 
regression curve fit). 
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Table 5. Personal care products EC50 values and respective 95% confidence interval for GSH 
content of hepatocytes, derived from a non-linear regression curve fit. 
 
AHTN HHCB DEP 
r
2
 0.044 
a
 0.262 0.023 
a
 
EC50 (M) 12.23 × 10
-9
 
a
 0.35 × 10
-6
 18.57 × 10
-9 a
 
EC50 95% CI (M) 0.04–3406 × 10
-9 a
 0.09–1.29 × 10
-6
 0.01 × 10
-12
–0.04 
a
 
 
 
 
3.2. ABC transporter activity  
The effects of inhibitors and PCPs on hepatocytes are quantified as dose-response 
curves and estimated as EC50 values. The data included in this analysis corresponds to 
three experimental replicates (n = 3, which means 24 pseudo-replicates). The 
fluorescence level of hepatocytes exposed to the solvent control DMSO was higher than 
for hepatocytes used as blank. However, reference to the toxic effect of DMSO is not 
considered relevant, since exposure groups are directly compared to the control group. In 
the figures, the concentrations of PCPs presented in red were excluded from the non-
linear regression curve fit, since they represent unviable cells and cannot be considered 
for this parameter. All individual experimental replicates can be found in Appendix II. 
3.2.1. Experimental results 
The ABC transporter activity of hepatocytes, after 24 h of exposure to inhibitors and PCPs 
as single compounds or binary mixtures, are summarized in this sub-section. The 
generated dose-response curves for VER and MK571 are sigmoidal and, considering the 
EC50 values, they seem to have a similar inhibitory potential (Figure 6 and Table 6). 
However, the individual experimental replicates for VER were not consistent (Figure 22, 
Appendix II); the first replicate was excluded from the data set, since experimental errors 
occurred which resulted in unknown concentrations of VER; the dose-response curve for 
the second replicate was non-sigmoidal with a shallow slope. For this reason, MK571 was 
selected as positive control and used in further data analysis.  
 
 
 
 
 
 
  a
 not conclusive values derived from a hypothetical non-linear regression curve fit  
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Table 6. Inhibitors EC50 values and respective 95% confidence interval for rhodamine 123 
accumulation on hepatocytes, derived from a non-linear regression curve fit. 
 
VER MK571 
r
2
 0.704 0.800 
EC50 (M) 2.80 × 10
-6
 3.06 × 10
-6
 
EC50 95% CI (M) 2.10–3.73 × 10
-6
 0.97–9.70 × 10
-6
 
 
 
The dose-response curves of hepatocytes exposed to single PCPs are sigmoidal (Figure 
7). The percentage of Rho123 accumulation in the cells was higher as the concentration 
increased. However, at concentrations ranging between 200–1000 × 10-6 M for AHTN, 
23.3–1000 × 10-6 M for HHCB and at 20 × 10-3 M for DEP, the PCPs were too toxic to the 
cells, which resulted in a drastic decrease of the Rho123 levels. In accordance with the 
results obtained for cytotoxicity testing, the highest toxic effect was generated in the 
presence of HHCB. Despite of DEP showing higher negative effects than AHTN at low 
concentrations, the EC50 values proved that AHTN (32.73 × 10
-6 M) is more toxic than 
DEP (0.13 × 10-3 M; Table 7). 
(A) (B) 
Figure 6. Rho123 accumulation on hepatocytes exposed to the inhibitors (A) VER and (B) MK571 
(% of control; mean ± standard deviation; n = 2 for VER; n = 3 for MK571; dotted lines: 95% 
confidence interval; C: control; red error bars: concentrations excluded from the non-linear 
regression curve fit). 
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Table 7. Personal care products EC50 values and respective 95% confidence interval for 
rhodamine 123 accumulation on hepatocytes, derived from a non-linear regression curve fit. 
 
AHTN HHCB DEP 
r
2
 0.634 0.703 0.544 
EC50 (M) 32.73 × 10
-6
 0.59 × 10
-6
 0.13 × 10
-3
 
EC50 95% CI (M) 24.65–43.45 × 10
-6
 0.42–0.82 × 10
-6
 0.07–0.25 × 10
-3
 
 
Hepatocytes exposed to binary mixtures of PCPs present a monotonous dose-response 
relationship (Figure 8). In the same manner as the single PCPs, from a certain 
concentration, the joint effect of PCPs is too high and the measured level of Rho123 in the 
cells drops. The combined effect of AHTN and HHCB on Rho123 accumulation is 
(A) (B) 
(C) (D) 
Figure 7. Rho123 accumulation on hepatocytes exposed to (A) AHTN, (B) HHCB, (C) DEP and (D) 
comparison of these three PCPs (% of MK571; mean ± standard deviation; n = 3; dotted lines: 95% 
confidence interval; C: control; red error bars: concentrations excluded from the non-linear 
regression curve fit). 
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intermediate compared to the single compound effects. Contrariwise, the combined effect 
of HHCB and DEP is lower than the effect of the single compounds. 
 
 
3.2.2. Model predictions 
The monotonous dose-response relationships of the CA and IA models were in 
agreement with the experimental relationships for hepatocytes exposed to PCPs; binary 
mixtures of these chemicals decrease the activity of ABC transporters as their 
concentration increases. The CA predictions for the joint effects of AHTN and HHCB are 
closer to the experimental results than the respective predictions for HHCB and DEP 
(Figure 9). However, the CA model deviates from the experimental EC50 values from both 
binary mixtures; the CA model predicts approximately two times lower effects for the 
(A) (B) 
(C) (D) 
Figure 8. Rho123 accumulation on hepatocytes exposed to a mixture of (A) AHTN and HHCB (B) 
HHCB and DEP and (C) comparison of indivudal and mixed AHTN and HHCB and (D) indivudal 
and mixed HHCB and DEP (% of MK571; mean ± standard deviation; n = 3; dotted lines: 95% 
confidence interval; C: control; red error bars: concentrations excluded from the non-linear 
regression curve fit). 
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mixture of AHTN and HHCB (values on Table 8) and approximately eighteen times higher 
effects for the mixture of HHCB and DEP (values on Table 9). For the later binary mixture, 
there is a significant difference between the experimental and predicted EC50 values (p < 
0.0001). Contrariwise, AHTN and HHCB experimental EC50 does not differ significantly 
from the predicted CA model value (p = 0.0608). 
 
 
 
The IA model predictions deviate from the observed effects of both binary mixtures; higher 
negative effects on the activity of ABC transporters are expected (Figure 10). However, 
the predicted EC50 value of 1.10 × 10
-6 M for the joint effects of AHTN and HHCB is much 
closer to its observed EC50 of 9.36 × 10
-6 M than the respective predictions for the joint 
effects of HHCB and DEP (values on Table 9). Likewise the CA model, a significant 
difference between the experimental and predicted EC50 values for the combined effects 
of HHCB and DEP was observed (p < 0.0001). Nevertheless, there are no significant 
(A) (B) 
(C) (D) 
Figure 9. CA model predictions of Rho123 accumulation on hepatocytes exposed to a mixture of 
(A) AHTN and HHCB (B) HHCB and DEP and (C) comparison of AHTN and HHCB experimental 
data with the model predictions and (D) HHCB and DEP experimental data with the model 
predictions (n = 3 for the experimental data; shade: 95% confidence interval). 
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deviations between the experimental and predicted EC50 for the mixture of AHTN and 
HHCB (p = 0.0541). 
 
 
 
Table 8. Experimental and predicted EC50 values and respective 95% confidence interval for 
rhodamine 123 accumulation on hepatocytes exposed to a mixture of AHTN and HHCB, derived 
from a non-linear regression curve fit (CA: concentration addition; IA: independent action). 
 
AHTN + HHCB 
 Experimental result 
Model prediction 
 
CA IA 
r
2
 0.616 1.0 0.999 
EC50 (M) 9.36 × 10
-6
 16.67 × 10
-6
 1.10 × 10
-6
 
EC50 95% CI (M) 7.21–12.15 × 10
-6
 16.64–16.70 × 10
-6
 0.83–1.46 × 10
-6
 
(A) (B) 
(C) (D) 
Figure 10. IA model predictions of Rho123 accumulation on hepatocytes exposed to a mixture of 
(A) AHTN and HHCB (B) HHCB and DEP and (C) comparison of AHTN and HHCB experimental 
data with the model predictions and (D) HHCB and DEP experimental data with the model 
predictions (n = 3 for the experimental data; dotted lines and shade: 95% confidence interval; red 
dots: concentrations excluded from the non-linear regression curve fit). 
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Table 9. Experimental and predicted EC50 values and respective 95% confidence interval for 
rhodamine 123 accumulation on hepatocytes exposed to a mixture of HHCB and DEP, derived 
from a non-linear regression curve fit (CA: concentration addition; IA: independent action). 
 
HHCB + DEP 
 Experimental result 
Model prediction 
 
CA IA 
r
2
 0.519 1.0 0.651 
EC50 (M) 1186 × 10
-6
 66.09 × 10
-6
 21.07 × 10
-6
 
EC50 95% CI (M) 712.20–1975 × 10
-6
 65.94–66.24 × 10
-6
 0.18–2424 × 10
-6
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4. Discussion 
4.1. Cytotoxicity testing 
4.1.1. Cell metabolic activity and membrane integrity 
The cytotoxic effects of rainbow trout hepatocytes exposed to PCPs were expressed 
through diverse changes in cellular structure and mechanisms of action, including 
mitochondrial activity, membrane integrity and induction of oxidative stress. The non-linear 
relationships of hepatocytes exposed to PCPs demonstrate that there is a dose-
dependent decrease of cellular metabolic activity and membrane integrity as the 
concentration of PCPs increases. Thus, exposure to increasing concentrations of these 
chemicals can directly or indirectly affect the electron transport chain, leading to an 
impairment of the metabolic function of mitochondria; indirect effects can derive from 
mitochondrial membrane disruption which also disrupts electron transport (Ostrander, 
2000). Impairment of hepatocytes plasma membrane also occurs as the concentration of 
PCPs increases, which translates into a decline of total esterase activity. This decline can 
be explained by partial or complete lysis of hepatocytes and consequent release of 
esterases into the medium (a posteriori removed) or occurrence of changes in the 
cytoplasmic milieu that influence the enzyme stability or its catalytic activity (Ostrander, 
2000). For the polycyclic musks, the fluorescent dye CFDA-AM seems to detect more 
severe effects than AB, since AHTN and HHCB affect membrane integrity of cells at lower 
concentrations than metabolic activity. This finding assumes that membrane disruption is 
affected prior to electron transport chain. However, tolerance of hepatocytes to higher 
concentrations of polycyclic musks seems to be greater at the level of membrane integrity 
than at the level of mitochondrial activity; higher concentrations of AHTN and HHCB are 
needed to affect total membrane integrity i.e. to produce 100% effect. Impairment of cell 
metabolism through exposure of rainbow trout cell lines to polycyclic musks was observed 
in previous studies. Through mitochondrial membrane permeabilization (MMP) testing, 
Randelli et al. (2011) suggest that AHTN induces early apoptosis in RTG-2 cells, with 
significant effects at 30 ng/mL (corresponding to 0.12 µM). In RTL-W1 cells, Schnell et al. 
(2009) concluded that AHTN diminishes energy metabolism and decreases membrane 
integrity at the same concentration (0.12 µM) and HHCB reveals significant cytotoxicity at 
1.2 µM. These findings are not in accordance with the results obtained in the present 
study, since polycyclic musks only elicit cytotoxic effects at higher concentrations and 
HHCB showed to be more toxic for rainbow trout hepatocytes than AHTN. According to 
the experimental results (Table 3 and Table 4), the 50% effect on hepatocytes metabolic 
activity was recorded at 237.6 µM (AHTN) and 4.71  µM (HHCB), whereas the membrane 
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integrity of 50% of the cells was impaired at 111.4 µM (AHTN) and 3.67 µM (HHCB). The 
difference in the order of magnitude between previous studies and the results obtained in 
the present work suggests that rainbow trout primary hepatocytes are a less sensitive 
model for in vitro cytotoxicity testing than cell lines. In relation to DEP, the observed toxic 
effects of this compound are much lower than for polycyclic musks (EC50 ~ 25 mM), which 
may be due to lower lipophilicity of this compound (log Kow of 2.47) in comparison to 
polycyclic musks (log Kow of 5.7–5.9). 
4.1.2. Oxidative stress 
Exposure of O. mykiss hepatocytes to certain concentrations of PCPs seems to elicit 
oxidative stress; the cellular GSH level was reduced which implies GSH conjugation with 
subsequent GSSG formation, leading to a lower intracellular GSH/GSSG ratio and 
subsequent oxidative stress. The response caused and the degree of toxicity depends on 
the compound in question, since HHCB seems to elicit a different dose-dependent pattern 
as AHTN and DEP. In the presence of HHCB at low concentration ranges (0.02–2.3 µM), 
hepatocytes seem to be able to cope with the formation of ROS and prevent oxidative 
damage; a dose-dependent increase in cellular GSH level indicates activation of 
antioxidant defenses. However, at higher concentrations of HHCB the cellular GSH level 
drops, which may suggest cell death through oxidative stress or other underlying 
mechanisms. Through the cellular morphology under microscopic observation, it was 
possible to observe that certain PCPs concentrations can cause mortality to hepatocytes. 
Chen et al. (2012) showed that fish exposed to simulated urban runoff, although being 
involved in oxidative stress, might be protected against the presence of HHCB through 
induction of antioxidant enzymes; verified for concentration ranges of 0.15–150 µg/L i.e. 
0.00058–0.58 µM.  
When evaluating the effects caused by the exposure of hepatocytes to AHTN and DEP, 
the phenomenon of hormesis seems to occur, since the dose-response relationships 
follow an inverted U-shaped pattern (i.e. increase at low concentrations followed by 
decrease at high concentrations). Hormesis is considered an “overcompensation to a 
disruption in homeostasis” (Calabrese, 1997). Low concentrations of these PCPs induce a 
stimulatory response in rainbow trout hepatocytes, which translates into an increment of 
cellular GSH levels. This stimulatory effect is around 40-60% greater than the control and 
likely is a protective mechanism against oxidative stress (Calabrese, 1997). However, at 
higher PCPs concentrations this over-compensatory response gives rise to an exhaustion 
of the cellular defense mechanisms, which translates into a decline of the GSH levels of 
hepatocytes. Thus, hepatocytes might be protected against damages caused by oxidative 
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stress at concentration ranges of 0.02–23.3 µM for AHTN and 2.3–20000 µM for DEP. 
Nevertheless, exposure to high concentrations of these PCPs may cause cell death due 
to the presence of excessive intracellular ROS, as previously suggested for other models. 
For example, in Paralichthys olivaceus liver the levels of GSH, GPx and GR increase after 
intraperitoneal injection of DEP (900 mg/kg for 3 days) indicating induction of antioxidant 
enzymes probably to cope with oxidative stress caused by the substance (Kang et al., 
2010). Zhang (2014) concluded that exposure of carp to DEP (0.5–8 mg/L; 2.3–36 µM) 
initially increases the activity of GPx which decreases at higher concentrations; this can 
compromise the antioxidant defense system. Additionally, DEP induced cell membrane 
lipid peroxidation resulting in cell damage, as indicated by the results from Zhang (2014). 
In contrast Zheng et al. (2013) showed that Carassius auratus liver after intraperitoneal 
injection of DEP (10 mg/kg for 10 days) presented lower GPx levels, which may indicate 
exhaustion of the antioxidant system and consequent accumulation of ROS. This 
inconsistency between results might be due to differences in dose and exposure time. As 
previously stated, membrane disruption seems to be affected prior to electron transport 
chain. Since xenobiotics interacting with the electron transport can trigger oxidative stress, 
it is likely that this cellular response occurs last. However, it is unclear if this is the correct 
sequence of events or if oxidative stress presents the most severe effects and causes 
impairment of hepatocytes plasma membrane. 
4.2. ABC transporter activity 
4.2.1. Experimental results 
The increasing intracellular accumulation of Rho123 (Figure 6, Figure 7 and Figure 8) 
indicates transporter activity reduction and subsequent MXR inhibition. Hepatocytes follow 
a dose-dependent increase in Rho123 accumulation as the concentration of inhibitors and 
PCPs increases, which is in agreement with the findings of Smital et al. (2004), 
Luckenbach & Epel (2005); only DEP at 20000 µM seems to induce a greater effect on 
hepatocytes Rho123 accumulation than the model inhibitor. Findings of Smital et al. 
(2004) and Luckenbach & Epel (2005) demonstrate significant increase in rhodamine B 
accumulation in Mytilus californianus gills exposed to synthetic musk fragrances, including 
AHTN and HHCB. Considering this, PCPs seem to be responsible for the inhibition of 
efflux transporters (i.e. to impair the MXR defense system against intracellular 
accumulation of xenobiotics). Furthermore, the potential of PCPs to block efflux 
transporters activity suggest that these chemicals act as chemosensitizers and 
compromise the elimination of other xenobiotics present in the organism. In this 
experiment it was not possible to determine which ABC transporter subfamilies were 
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affected, since hepatocytes were not simultaneously exposed to the model inhibitors VER 
and MK571 and to PCPs. 
Inhibition of ABC transport activity was also verified for hepatocytes exposed to binary 
mixtures of PCPs. In the same manner as the measured cytotoxicity parameters, single 
HHCB elicited the most severe effects. However, when HHCB was combined with DEP, 
the binary mixture revealed lower toxicity than the single compounds. These results 
suggest that the high inhibitory potential of HHCB is not due to the presence of DEP in the 
commercial galaxolide solution (HHCB, 50% in DEP). Furthermore, interactions seem to 
occur between these two PCPs resulting in an antagonistic effect. The potential of the 
binary mixture of AHTN and HHCB to inhibit the MXR defense mechanism of hepatocytes 
was intermediate between the potential of the respective single compounds i.e., the 
combination of the two polycyclic musks seems to elicit a lower effect than the most toxic 
compound (HHCB) and a greater effect than the less toxic compound (AHTN). This 
suggests that indirect interactions occur when AHTN and HHCB are present in a mixture. 
Nevertheless, the combined effects of a mixture of polycyclic musks are much severe than 
the combined effects of galaxolide and diethyl phthalate. 
4.2.2. Model predictions 
The PCPs used in this study are considered endocrine disruptors belonging to two 
different categories: AHTN and HHCB have antiestrogenic effects and DEP is considered 
antiandrogenic (Witorsch & Thomas, 2010). The dose-response relationship of the binary 
mixture consisting of polycyclic musks behaves according to the CA model predictions, 
since experimental and predicted EC50 values were not significantly different, meaning 
that the mixture of AHTN and HHCB induced additive effects on O. mykiss hepatocytes. 
Luckenbach & Epel (2005) and Schnell et al. (2009) stated the same findings i.e. that the 
MXR inhibitory potential of combined musks is additive. Additionally, Kortenkamp et al. 
(2007) showed that mixture effects of endocrine disruptors belonging to the same 
category can be predicted through the CA model. This confirms that CA is a good 
reference model for toxicity predictions of chemicals sharing the same mechanism of 
action. In contrast, the results obtained for the HHCB/DEP mixture indicate that the 
combined effects induced by these two PCPs do not behave according to the CA and IA 
model predictions, since significant differences were observed between experimental and 
predicted EC50 values. Deviations from these predictions can be interpreted as 
interactions which in this case are antagonistic, since the combined effects of these two 
PCPs were lower than expected. This may be due to the different mechanisms of toxic 
action of the tested substances (HHCB has an antiestrogenic effect, while DEP has an 
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antiandrogenic action; Witorsch & Thomas, 2010). Since CA and IA models predictions 
were similar, both models seem to be suitable to assess combined effects of substances 
with diverse modes of action.  
4.3. Assessment of primary hepatocyte viability 
Hepatocytes of rainbow trout were successfully isolated using a two-step perfusion and 
maintained as primary cell cultures. Before starting a culture, the cell viability was high, 
with values greater than 80% and hepatocytes with a round shape. However, during the 
incubation period the viability of cells was declining and the density was lower than 
expected (cell sometimes were less than 70% confluent). In some cases, it was possible 
to observe that hepatocytes were entering in a cell death process because some 
hepatocytes were starting to acquire a different shape, to shrink and to agglomerate. 
Although being natural that hepatocytes in a culture de-differentiate and consequently 
diverse morphological and structural changes occur, this fact is not sufficient to explain 
the observed low density of the cell monolayer (Soldatow et al., 2013). The isolation 
technique implied the action of an enzyme to disaggregate the tissue followed by 
mechanical disruption; therefore, bacterial collagenase (type VII) was selected to perform 
an in situ liver perfusion. The enzymatic digestion is critical to the establishment of 
functional cultures; its performance can be affected by the enzyme type and respective 
concentration in solution, exposure time and circulation conditions. The experimental 
design could have failed in this step and no digestion occurred, since previous primary 
fish hepatocyte cultures were successfully established by using collagenase type IV 
(Ellesat et al., 2010 & 2011). Furthermore, exposure of liver cells to the perfusion buffer 
containing collagenase could have been too long for the size of the fish or too located, 
since in situ perfusion reduces the recirculation level of the solution (Segner, 1998). 
Taking into account observations made throughout this experiment, shorter periods of 
exposure to collagenase (maximum 10 min) are suggested for juvenile rainbow trout; 
removal of the liver between the first and the second perfusion step could be a solution to 
facilitate recirculation and overcome local loss of cell viability. In order to improve culture 
conditions and avoid losses in cell functionality over time, more attention should be given 
to parameters that influence the physiological state of cells (Hodne et al., 2012). For 
instance, osmotic stress can be induced if osmolality of culture mediums are below the 
plasma osmolality of fish (Hodne et al., 2012). Even though osmolality of the medium and 
solutions were adjusted to physiological values, adjustment in pH and temperature should 
be better monitored. The pH of the solutions and medium used throughout the hepatocyte 
isolation and culture were ranging between 7.5–7.6. Nevertheless, these measurements 
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were done before the sterile filtration and incubation; factors such as rise of pH after 
filtration and influence of CO2 level and temperature in culture were not considered. 
Therefore, the initial measured pH value is not a good indicator of the final value in 
culture. The pH in culture should be similar to the plasma pH of the fish (in teleosts, it 
ranges between 7.7–7.9; Hodne et al., 2012). Regarding the temperature, 15 °C was 
proven to be adequate in the maintenance of rainbow trout hepatocytes (Ellesat et al., 
2010). However, Segner (1998) showed that cell viability over time was greater for O. 
mykiss hepatocytes maintained at 10 °C than at 14 °C. These findings suggest that 
temperature of cell cultures should be closer to the water conditions of the environment 
where fish was maintained before being sacrificed. Culture conditions should be as close 
as possible to the natural environment values of the organism to avoid additional stress 
factors and extend cell culture longevity. 
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5. Conclusions 
Exposure of O. mykiss hepatocytes to three common personal care products, including 
AHTN, HHCB and DEP revealed to cause toxic effects. Increasing concentrations of 
PCPs affected the metabolic function of mitochondria and caused cellular membrane 
disruption, following a dose-response relationship. At high PCPs concentrations, the 
electron transport chain impairment and consequent mitochondrial dysfunction can result 
in oxidative stress. At low PCPs concentrations, hepatocytes seem to cope with the 
presence of ROS through induction of the antioxidant defense system. These findings 
corroborate the first hypothesis, namely that exposure to PCPs causes a dose-dependent 
cytotoxic effect on O. mykiss hepatocytes. However, for the oxidative stress parameter, 
AHTN and DEP did not follow a sigmoidal dose-response relationship; these substances 
seem to act in accordance with the hormesis dose-response phenomenon.  
PCPs decreased the ABC transporter activity of hepatocytes as the concentration 
increased i.e. in a dose-dependent manner. Thus, the second hypothesis was verified, 
namely that there is a dose-dependent decrease in ABC transporter activity of O. mykiss 
hepatocytes after exposure to single PCPs. This means that these substances inhibit the 
MXR defense mechanism of hepatocytes and intracellular accumulation of xenobiotics 
can occur. Consequently, PCPs can act as chemosensitizers and in its presence, 
organisms become more susceptible to exposure to other xenobiotics present in the 
environment.  
The results of the present study also indicated toxicological interactions between the 
binary mixtures of PCPs tested at the ABC transporter activity level, thus corroborating the 
third hypothesis. The combined effects of the two tested polycyclic musks were in 
agreement with CA model predictions. This means that the toxic effects induced on the 
ABC transporter activity, by the simultaneous exposure of hepatocytes to AHTN and 
HHCB, were additive. The HHCB/DEP binary mixture effects were neither in accordance 
with CA nor with IA model predictions; the toxicity of the mixture was lower than predicted 
which indicates that interactions occur between these two PCPs i.e. the HHCB/DEP 
mixture effects on ABC transporter activity were antagonistic. 
Polycyclic musks and diethyl phthalate are present in surface waters at much lower levels 
than the concentration ranges tested in this experiment. However, it is important to take 
into consideration that these chemicals can accumulate in the aquatic system and adsorb 
to sediments, increasing its concentration in the environment. Therefore, these PCPs are 
available to aquatic organisms and can trigger mechanism of toxicity. Nevertheless, it is 
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important to evaluate the toxic effects of PCPs at environmental relevant concentrations 
and perform short and long-term exposure experiments with aquatic organisms. Thus, 
acute and chronic effects can be assessed and, at the same time, the recovery potential 
of these organisms can be evaluated. Further research is needed to better understand the 
mechanism involved in oxidative stress and to determine the presence and expression of 
ABC proteins in hepatocytes, since isolation and culture of hepatocytes can affect the 
expression profile of these transporters. Additionally, it is important to obtain a broad view 
of the consequences of such exposures and be able to understand them at a population 
and ecosystem level. 
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Appendix I 
 
Table 10. Chemicals used throughout the experiment. 
Product Producer Supplier Product No. CAS No. 
1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-
hexamethylcyclopenta[g]-2-
benzopyran solution 
 
Sigma-Aldrich W520608 
122-05-
05 
5-carboxyfluorescein diacetate 
acetoxymethyl ester 
Invitrogen, Life 
technologies  
C1354 
124412-
00-6 
6-Acetyl-1,1,2,4,4,7-
hexamethyltetralin  
Sigma-Aldrich W526401 
21145-
77-7 
Alamar blue 
Invitrogen, Life 
technologies  
DAL1025 
62758-
13-8 
Antibiotic antimycotic solution 
(100×), with 10000 units penicillin, 
10 mg streptomycin and 25 μg 
amphotericin B per mL 
Gibco, Life 
technologies  
15240 
 
Bovine serum albumin 
 
Sigma-Aldrich A4503 
9048-46-
8 
CaCl2  
Sigma-Aldrich C1016 
10043-
52-4 
Collagenase VIII 
 
Sigma-Aldrich C2139 
9001-12-
1 
Diethyl phthalate 
 
Sigma-Aldrich 524972 84-66-2 
Dimethyl sulfoxide Amresco 
 
231 67-68-5 
Ethylene glycol tetraacetic acid 
 
Sigma-Aldrich E4378 67-42-5 
KCl 
Merck 
Millipore 
VWR 1.04936 
7447-40-
7 
L-15 (Leibovitz) medium with L-
glutamine   
Sigma-Aldrich L4386 
 
MgSO4 × 7H2O 
Merck 
Millipore 
VWR 1.05886 
10034-
99-8 
MK 571 (sodium salt) 
Cayman 
Chemical  
70720 
115103-
85-0 
Monochlorobimane 
 
Sigma-Aldrich 69899 
76421-
73-3 
Na2HPO4  
Sigma-Aldrich S5136 
7558-79-
4 
NaCl 
AnalaR 
Normapur 
VWR 27810.295 
7647-14-
5 
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NaH2PO4 × H2O  
Sigma-Aldrich 71504 
10049-
21-5 
NaHCO3  
Sigma-Aldrich S5761 144-55-8 
Phosphate buffered saline 
 
Sigma-Aldrich P4417 
 
Rhodamine 123 
Molecular 
Probes  
R-302 
62669-
70-9 
Sodium bicarbonate solution 
 
Sigma-Aldrich S8761 144-55-8 
Triton X-100 
 
Sigma-Aldrich X100 
9002-93-
1 
Trizma base 
 
Sigma-Aldrich T1503 77-86-1 
Trizma hydrochloride 
 
Sigma-Aldrich T5941 
1185-53-
1 
Trypan blue solution 
 
Sigma-Aldrich T8154 72-57-1 
Verapamil hydrochloride 
 
Sigma-Aldrich V4629 152-11-4 
 
 
Table 11. Composition of solutions used throughout the experiment. These solutions were 
sterilized by filtration (0.22 µm). 
Solution Chemical Concentration 
Perfusion buffer 
pH 7.5 
310 mOsm 
KCl 4.8 mM 
MgSO4 × 7H2O 1.2 mM 
Na2HPO4 11 mM 
NaCl 122 mM 
NaH2PO4 × H2O 3.3 mM 
NaHCO3 3.7 mM 
Tris-buffer (50 µM) 
pH 7.4 
Trizma base 8 µM 
Trizma hydrochloride 42 µM 
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Blank Control AHTN or HHCB (×10
-6
 M) 
 
  1 2 3 4 5 6 7 8 9 10 11 12 
A Cells DMSO  0.02 0.2  2.3 23.3 200 1000         
B Cells DMSO  0.02 0.2  2.3 23.3 200 1000         
C Cells DMSO  0.02 0.2 2.3 23.3 200 1000         
D Cells DMSO  0.02 0.2 2.3 23.3 200 1000         
E Cells DMSO  0.02 0.2 2.3 23.3 200 1000         
F Cells DMSO  0.02 0.2 2.3 23.3 200 1000         
G Cells DMSO  0.02 0.2 2.3 23.3 200 1000         
H Cells DMSO  0.02 0.2 2.3 23.3 200 1000         
             
 
Blank Control DEP (×10
-6
 M) 
    
  1 2 3 4 5 6 7 8 9 10 11 12 
A Cells DMSO 2.3 23.3 232.8 2328 20000 100000         
B Cells DMSO 2.3 23.3 232.8 2328 20000 100000         
C Cells DMSO 2.3 23.3 232.8 2328 20000 100000         
D Cells DMSO 2.3 23.3 232.8 2328 20000 100000         
E Cells DMSO 2.3 23.3 232.8 2328 20000 100000         
F Cells DMSO 2.3 23.3 232.8 2328 20000 100000         
G Cells DMSO 2.3 23.3 232.8 2328 20000 100000         
H Cells DMSO 2.3 23.3 232.8 2328 20000 100000         
             
 
Blank Control Inhibitor (×10
-6
 M) 
    
  1 2 3 4 5 6 7 8 9 10 11 12 
A Cells DMSO 0.1 0.3 1.7 8.5 10 50         
B Cells DMSO 0.1 0.3 1.7 8.5 10 50         
C Cells DMSO 0.1 0.3 1.7 8.5 10 50         
D Cells DMSO 0.1 0.3 1.7 8.5 10 50         
E Cells DMSO 0.1 0.3 1.7 8.5 10 50         
F Cells DMSO 0.1 0.3 1.7 8.5 10 50         
G Cells DMSO 0.1 0.3 1.7 8.5 10 50         
H Cells DMSO 0.1 0.3 1.7 8.5 10 50         
Figure 11. Plate design for O. mykiss hepatocytes exposed to single compounds (AHTN, HHCB 
and DEP) and inhibitors (VER and MK571). Blank corresponds to wells only with cells, control 
corresponds to cells exposed to the solvent control DMSO and the remaining wells correspond to 
cells exposed to different concentrations of personal care products or inhibitors. 
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Blank Control AHTN + HHCB (×10
-6
 M) 
 
  1 2 3 4 5 6 7 8 9 10 11 12 
A Cells DMSO 
0.06  
0.06 
0.56 
0.56  
5.6     
5.6  
56         
56  
100       
100  
1000    
1000  
        
B Cells DMSO 
0.06  
0.06 
0.56 
0.56  
5.6     
5.6  
56         
56  
100       
100  
1000    
1000  
        
C Cells DMSO 
0.06  
0.06 
0.56 
0.56 
5.6     
5.6 
56         
56  
100       
100  
1000    
1000  
        
D Cells DMSO 
0.06  
0.06 
0.56 
0.56 
5.6     
5.6 
56         
56  
100       
100  
1000    
1000  
        
E Cells DMSO 
0.06  
0.06 
0.56 
0.56 
5.6     
5.6 
56         
56  
100       
100  
1000    
1000  
        
F Cells DMSO 
0.06  
0.06 
0.56 
0.56 
5.6     
5.6 
56         
56  
100       
100  
1000    
1000  
        
G Cells DMSO 
0.06  
0.06 
0.56 
0.56 
5.6     
5.6 
56         
56  
100       
100  
1000    
1000  
        
H Cells DMSO 
0.06  
0.06 
0.56 
0.56 
5.6     
5.6 
56         
56  
100       
100  
1000    
1000  
        
     
 
Blank Control HHCB + DEP (×10
-6
 M) 
    
  1 2 3 4 5 6 7 8 9 10 11 12 
A Cells DMSO 
0.06   
5.6  
0.56    
56   
5.6    
557 
56     
5571 
100  
10000  
1000 
100000 
        
B Cells DMSO 
0.06   
5.6  
0.56    
56   
5.6    
557 
56     
5571 
100  
10000  
1000 
100000 
        
C Cells DMSO 
0.06   
5.6 
0.56    
56 
5.6    
557 
56     
5571 
100  
10000  
1000 
100000 
        
D Cells DMSO 
0.06   
5.6 
0.56    
56 
5.6    
557 
56     
5571 
100  
10000  
1000 
100000 
        
E Cells DMSO 
0.06   
5.6 
0.56    
56 
5.6    
557 
56     
5571 
100  
10000  
1000 
100000 
        
F Cells DMSO 
0.06   
5.6 
0.56    
56 
5.6    
557 
56     
5571 
100  
10000  
1000 
100000 
        
G Cells DMSO 
0.06   
5.6 
0.56    
56 
5.6    
557 
56     
5571 
100  
10000  
1000 
100000 
        
H Cells DMSO 
0.06   
5.6 
0.56    
56 
5.6    
557 
56     
5571 
100  
10000  
1000 
100000 
        
Figure 12. Plate design for O. mykiss hepatocytes exposed to a personal care products mixture of 
AHTN/HHCB and HHCB/DEP. Blank corresponds to wells only with cells and control corresponds 
to cells exposed to the solvent control DMSO. The remaining wells represent cells exposed to two 
PCPs with different concentrations (top line, concentration of 1
st
 compound; bottom line, 
concentration of 2
nd
 compound). 
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Appendix II 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(A) (B) 
(C) 
Figure 13. Mitochondrial activity of hepatocytes exposed to AHTN at the (A) first replicate (B) 
second replicate and (C) third replicate (% of control; mean ± standard deviation; C: control). 
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(A) (B) 
(C) 
Figure 14. Mitochondrial activity of hepatocytes exposed to HHCB at the (A) first replicate (B) 
second replicate and (C) third replicate (% of control; mean ± standard deviation; dotted lines: 95% 
confidence interval; C: control). 
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(A) (B) 
(C) 
Figure 15. Mitochondrial activity of hepatocytes exposed to DEP at the (A) first replicate (B) 
second replicate and (C) third replicate (% of control; mean ± standard deviation; C: control). 
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(A) (B) 
(C) 
Figure 16. Membrane integrity of hepatocytes exposed to AHTN at the (A) first replicate (B) second 
replicate and (C) third replicate (% of control; mean ± standard deviation; dotted lines: 95% 
confidence interval; C: control). 
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(A) (B) 
(C) 
Figure 17. Membrane integrity of hepatocytes exposed to HHCB at the (A) first replicate (B) 
second replicate and (C) third replicate (% of control; mean ± standard deviation; dotted lines: 95% 
confidence interval; C: control). 
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(A) (B) 
(C) 
Figure 18. Membrane integrity of hepatocytes exposed to DEP at the (A) first replicate (B) second 
replicate and (C) third replicate (% of control; mean ± standard deviation; C: control). 
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(A) (B) 
(C) 
Figure 19. GSH content of hepatocytes exposed to AHTN at the (A) first replicate (B) second 
replicate and (C) third replicate (% of control; mean ± standard deviation; C: control; red error bars: 
concentrations excluded from the graphical analysis). 
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(A) (B) 
(C) 
Figure 20. GSH content of hepatocytes exposed to HHCB at the (A) first replicate (B) second 
replicate and (C) third replicate (% of control; mean ± standard deviation; C: control; red error bars: 
concentrations excluded from the non-linear regression curve fit and graphical analysis). 
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(A) (B) 
(C) 
Figure 21. GSH content of hepatocytes exposed to DEP at the (A) first replicate (B) second 
replicate and (C) third replicate (% of control; mean ± standard deviation; C: control; red error bars: 
concentrations excluded from the graphical analysis). 
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(A) (B) 
(C) 
Figure 22. Rho123 accumulation on hepatocytes exposed to the inhibitor VER at the (A) first 
replicate (B) second replicate and (C) third replicate (% of control; mean ± standard deviation; 
dotted lines: 95% confidence interval; C: control; red error bars: concentrations excluded from the 
non-linear regression curve fit). 
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(A) (B) 
(C) 
Figure 23. Rho123 accumulation on hepatocytes exposed to the inhibitor MK571 at the (A) first 
replicate (B) second replicate and (C) third replicate (% of control; mean ± standard deviation; 
dotted lines: 95% confidence interval; C: control; red error bars: concentrations excluded from the 
non-linear regression curve fit). 
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(A) (B) 
(C) 
Figure 24. Rho123 accumulation on hepatocytes exposed to AHTN at the (A) first replicate (B) 
second replicate and (C) third replicate (% of MK571; mean ± standard deviation; dotted lines: 95% 
confidence interval; C: control; red error bars: concentrations excluded from the non-linear 
regression curve fit). 
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(A) (B) 
(C) 
Figure 25. Rho123 accumulation on hepatocytes exposed to HHCB at the (A) first replicate (B) 
second replicate and (C) third replicate (% of MK571; mean ± standard deviation; dotted lines: 95% 
confidence interval; C: control; red error bars: concentrations excluded from the non-linear 
regression curve fit). 
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(A) (B) 
(C) 
Figure 26. Rho123 accumulation on hepatocytes exposed to DEP at the (A) first replicate (B) 
second replicate and (C) third replicate (% of MK571; mean ± standard deviation; dotted lines: 95% 
confidence interval; C: control; red error bars: concentrations excluded from the non-linear 
regression curve fit). 
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(A) (B) 
(C) 
Figure 27. Rho123 accumulation on hepatocytes exposed to a mixture of AHTN and HHCB at the 
(A) first replicate (B) second replicate and (C) third replicate (% of MK571; mean ± standard 
deviation; dotted lines: 95% confidence interval; C: control; red error bars: concentrations excluded 
from the non-linear regression curve fit). 
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(A) (B) 
(C) 
Figure 28. Rho123 accumulation on hepatocytes exposed to a mixture of HHCB and DEP at the 
(A) first replicate (B) second replicate and (C) third replicate (% of MK571; mean ± standard 
deviation; dotted lines: 95% confidence interval; C: control; red error bars: concentrations excluded 
from the non-linear regression curve fit). 
